Fortis, RHT extend last date for completing acquisition
FHL is in process of raising funds via primary infusion which will enable it to acquire the RHT assets. The fund raise process is under way and awaiting regulatory approvals, it added.
FUND
-
Carlyle Group sells 4.3% in Indegene for ₹636 cr
According to the bulk deal data available on the National Stock Exchange (NSE), CA Dawn Investments, an affiliate of US-based Carlyle, sold 1,02,63,785 shares amounting to a 4.3% stake in Indegene.
-
Torrent Pharma is said to seek raising $3 billion for KKR’s stake in JB Chemicals
-
State govt allots 10cr for projects at MCH
-
No discrimination between States on funds disbursal: Health Minister
-
Eight Roads launches $250 million healthcare and lifescience fund
-
Pakistan government to impose 'sin tax' on tobacco
-
Norway biotech Ultimovacs plans IPO to develop cancer drug
-
Dehradun: Doctors express ire at state govt’s decisions
-
Policybazaar Group pumps $50 million in docprime.com
Advertisement
More in FUND
-
-
TPG, KKR leading contenders to manage Abraaj's healthcare fund: sources
The two firms have access to the healthcare fund's virtual data room and are about to start due diligence, with offers expected in the next few weeks, two of the three sources said.
-
Oncology solutions company Mitra Biotech gets $40 million
Boston and Bengaluru-based Mitra Biotech develops and provides novel technologies that personalise cancer treatment.
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
